Ondansetron Hydrochloride

CAS 99614-02-5 20 current records 1 historicalSmall Molecule

Who holds supplier records for Ondansetron Hydrochloride? 20 organisations hold a current record for Ondansetron Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 16 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), Israel (2), United States (1), Spain (1) and 4 other countries (4); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ondansetron Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ondansetron-hydrochloride

Reading the evidence

  • 20 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 14 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (20)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ondansetron Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Ondansetron Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (16)

Certificates of Suitability on the EDQM register for Ondansetron Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 19 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HIKAL LIMITED BengaluruIN
CEP 2005-012 - Rev 06
Ondansetron hydrochloride dihydrate
Jul 2026Inspected Nov 2025
Switzerland
VIYASH SCIENTIFIC LIMITED HyderabadIN
CEP 2019-252 - Rev 02
Ondansetron hydrochloride dihydrate
Jul 2026—
TAPI NL B.V. AmsterdamNL
CEP 2004-042 - Rev 04
Ondansetron hydrochloride dihydrate
Apr 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2025-398 - Rev 00
Ondansetron hydrochloride dihydrate, Process-II
Nov 2025—
CIPLA LIMITED MumbaiIN
CEP 2006-279 - Rev 04
Ondansetron hydrochloride dihydrate
Feb 2025—
NATCO PHARMA LIMITED HyderabadIN
CEP 2003-221 - Rev 05
Ondansetron hydrochloride dihydrate
Oct 2023—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2005-071 - Rev 06
Ondansetron hydrochloride dihydrate
May 2023—
SHODHANA LABORATORIES PRIVATE LIMITED JeedimetlaIN
R1-CEP 2009-114 - Rev 01
Ondansetron hydrochloride dihydrate
May 2023—
QILU PHARMACEUTICAL CO., LTD. JinanCN
R1-CEP 2008-174 - Rev 04
Ondansetron hydrochloride dihydrate
Feb 2023—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
R1-CEP 2004-066 - Rev 04
Ondansetron hydrochloride dihydrate
Aug 2022—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
R1-CEP 2004-209 - Rev 03
Ondansetron hydrochloride dihydrate
Mar 2020—
IPCA Laboratories Limited MumbaiIN
R1-CEP 2007-237 - Rev 02
Ondansetron hydrochloride dihydrate
Sept 2019—
SMS PHARMACEUTICALS LIMITED HyderabadIN
R1-CEP 2009-319 - Rev 04
Ondansetron hydrochloride dihydrate
Sept 2019—
INKE, S.A. CastellbisbalES
R1-CEP 2005-056 - Rev 00
Ondansetron hydrochloride dihydrate
May 2012—
CAMBREX CHARLES CITY, INC. Charles CityUS
R1-CEP 2003-130 - Rev 01
Ondansetron hydrochloride dihydrate
Dec 2011—
GEDEON RICHTER PLC. BudapestHU
R1-CEP 2003-053 - Rev 01
Ondansetron hydrochloride dihydrate
Aug 2011—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Ondansetron Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • CHEMSOURCE CORP
    Inactive DMF 15783 · filed Dec 2001

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Ondansetron Hydrochloride is a selective serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Chemical identity

IUPAC name
9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;dihydrate;hydrochloride
Canonical SMILES
CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.O.O.Cl
InChIKey
VRSLTNZJOUZKLX-UHFFFAOYSA-N
Synonyms
Zofran API, gr 38032f, gr-38032f, gr-c507/75, odansetron hydrochloride, ondansetron (as hydrochloride), ondansetron hcl, ondansetron hydrochloride dihydrate, ondansetron hydrochloride hydrate, ondansetron monohydrochloride, sn 307, sn-307

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin-3 Receptor Antagonist
Mechanism of action
Serotonin 3 Receptor Antagonists

Therapeutic areas

GastroenterologyOncologySurgery

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ondansetron Hydrochloride?

20 organisations hold an active US FDA Type II Drug Master File or a CEP for Ondansetron Hydrochloride: Natco Pharma (India), APITORIA PHARMA PRIVATE LTD (India), Cadila Pharmaceuticals Limited (India), CAMBREX CHARLES CITY INC (United States), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India), HIKAL LTD (India) and INKE SA (Spain), and 12 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ondansetron Hydrochloride Drug Master Files are active?

Natco Pharma (DMF 20675, 18180), APITORIA PHARMA PRIVATE LTD (DMF 19071), Cadila Pharmaceuticals Limited (DMF 16786), CAMBREX CHARLES CITY INC (DMF 15752), Cipla Limited (DMF 15724), Dr. Reddy's Laboratories Ltd. (DMF 15436), HIKAL LTD (DMF 16710) and INKE SA (DMF 16317) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ondansetron Hydrochloride records mean?

1 organisation has only inactive Type II DMFs for Ondansetron Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ondansetron Hydrochloride have a European Certificate of Suitability?

Yes. 16 organisations hold a valid CEP for Ondansetron Hydrochloride on the EDQM register, including HIKAL LIMITED Bengaluru (IN), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), TAPI NL B.V. Amsterdam (NL), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), CIPLA LIMITED Mumbai (IN) and NATCO PHARMA LIMITED Hyderabad (IN) and 10 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Ondansetron Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ondansetron Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.